Expression and prognostic significance of microRNAs in Korean patients with myelodysplastic syndrome
3
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Various alterations of microRNA (miRNA) expression have been reported in myelodysplastic syndrome (MDS). We aimed to investigate the unique patterns and prognostic significance of miRNA expression in Korean patients with MDS. Methods: Bone marrow mononuclear cells were collected from eight healthy controls and 26 patients with MDS, and miRNAs were isolated and assessed via quantitative real-time polymerase chain reaction for selected miRNAs, including miR-21, miR-124a, miR-126, miR-146b-5p, miR-155, miR-182, miR-200c, miR-342- 5p, miR-708, and Let-7a. Results: MiR-124a, miR-155, miR-182, miR-200c, miR-342-5p, and Let-7a were significantly underexpressed in patients with MDS, compared to healthy controls. MiR-21, miR-126, 146b-5p, and miR-155 transcript levels were significantly lower in international prognostic scoring system lower (low and intermediate-1) risk MDS than in higher (intermediate-2 and high) risk MDS. Higher expression levels of miR-126 and miR-155 correlated with significantly shorter overall survival and leukemia-free survival. Higher miR-124a expression also tended to be related to shorter survivals. Conclusions: Although our study was limited by the relatively small number of patients included, we identified several miRNAs associated with pathogenesis, leukemic transformation, and prognosis in MDS.
Abstract
Background/Aims: Various alterations of microRNA (miRNA) expression have been reported in myelodysplastic syndrome (MDS). We aimed to investigate the unique patterns and prognostic significance of miRNA expression in Korean patients with MDS. Methods: Bone marrow mononuclear cells were collected from eight healthy controls and 26 patients with MDS, and miRNAs were isolated and assessed via quantitative real-time polymerase chain reaction for selected miRNAs, including miR-21, miR-124a, miR-126, miR-146b-5p, miR-155, miR-182, miR-200c, miR-342- 5p, miR-708, and Let-7a. Results: MiR-124a, miR-155, miR-182, miR-200c, miR-342-5p, and Let-7a were significantly underexpressed in patients with MDS, compared to healthy controls. MiR-21, miR-126, 146b-5p, and miR-155 transcript levels were significantly lower in international prognostic scoring system lower (low and intermediate-1) risk MDS than in higher (intermediate-2 and high) risk MDS. Higher expression levels of miR-126 and miR-155 correlated with significantly shorter overall survival and leukemia-free survival. Higher miR-124a expression also tended to be related to shorter survivals. Conclusions: Although our study was limited by the relatively small number of patients included, we identified several miRNAs associated with pathogenesis, leukemic transformation, and prognosis in MDS.
참고문헌 (36)
- List AF, "Myelodysplastic syndromes", Hematology Am Soc Hematol Educ Program, pp.297~317 (2004)
- Eun-Hye Park, "Nationwide statistical analysis of myeloid malignancies in Korea: incidence and survival rate from 1999 to 2012", Blood Research, 50(4), pp.204~217 (2015), 대한혈액학회
- Greenberg P, "International scoring system for evaluating prognosis in myelodysplastic syndromes", Blood, 89, pp.2079~2088 (1997)
- Greenberg PL, "Revised international prognostic scoring system for myelodysplastic syndromes", Blood, 120, pp.2454~2465 (2012)
- Rhyasen GW, "Deregulation of microRNAs in myelodysplastic syndrome", Leukemia, 26, pp.13~22 (2012)
- Bartel DP, "MicroRNAs : genomics, biogenesis, mechanism, and function", Cell, 116, pp.281~297 (2004)
- Khraiwesh B, "Transcriptional control of gene expression by microRNAs", Cell, 140, pp.111~122 (2010)
- O’Connell RM, "MicroRNA function in myeloid biology", Blood, 118, pp.2960~2969 (2011)
- Choi JS, "MicroRNA-194-5p could serve as a diagnostic and prognostic biomarker in myelodysplastic syndromes", Leuk Res, 39, pp.763~768 (2015)
- Kim Y, "Serum microRNA-21as a potential biomarker for response to hypomethylating agents in myelodysplastic syndromes", PLoS One, 9, pp.e86933~ (2014)
- Vasilatou D, "Expression analysis of mir-17-5p, mir-20a and let-7a microRNAs and their target proteins in CD34+ bone marrow cells of patients with myelodysplastic syndromes", Leuk Res, 37, pp.251~258 (2013)
- Vardiman JW, "The 2008 revision of the World Health Organization(WHO)classification of myeloid neoplasms and acute leukemia : rationale and important changes", Blood, 114, pp.937~951 (2009)
- "miRTarBase" (2016)[URL]
- Shelygin YA, "The analysis of microRNAs miR-200C and miR-145 expression in colorectal cancer of different molecular subtypes", Dokl Biochem Biophys, 463, pp.243~246 (2015)
- Ibrahim FF, "MicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancer", J Ovarian Res, 8, pp.56~ (2015)
- Wang X, "miR-200c targets CDK2and suppresses tumorigenesis in renal cell carcinoma", Mol Cancer Res, 13, pp.1567~1577 (2015)
- Wang J, "Overexpressions of microRNA-9 and microRNA-200c in human breast cancers are associated with lymph node metastasis", Cancer Biother Radiopharm, 28, pp.283~288 (2013)
- Cochrane DR, "MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents", Mol Cancer Ther, 8, pp.1055~1066 (2009)
- Shi J, "Expression of cell cycle control genes in myelodysplastic syndromes", Zhonghua Xue Ye Xue Za Zhi, 26, pp.10~14 (2005)
- Jia JS, "Expression of cyclin A1 mRNA in patients with myelodysplastic syndrome and its clinical significance", Zhongguo Shi Yan Xue Ye Xue Za Zhi, 17, pp.377~381 (2009)
- Hussein K, "Aberrant microRNA expression pattern in myelodysplastic bone marrow cells", Leuk Res, 34, pp.1169~1174 (2010)
- Votavova H, "Differential expression of microRNAs in CD34+ cells of 5q-syndrome", J Hematol Oncol, 4, pp.1~ (2011)
- Sokol L, "Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes", Br J Haematol, 153, pp.24~32 (2011)
- Dickstein J, "Methylation and silencing of miRNA-124 by EVI1 and self-renewal exhaustion of hematopoietic stem cells in murine myelodysplastic syndrome", Proc Natl Acad Sci U S A, 107, pp.9783~9788 (2010)
- Bhagat TD, "miR-21 mediates hematopoietic suppression in MDS by activating TGF-βsignaling", Blood, 121, pp.2875~2881 (2013)
- Lee DW, "Loss of SHIP-1 protein expression in high-risk myelodysplastic syndromes is associated with miR-210 and miR-155", Oncogene, 31, pp.4085~4094 (2012)
- Zhai PF, "The regulatory roles of microRNA-146b-5p and its target platelet-derived growth factor receptor α(PDGFRA)in erythropoiesis and megakaryocytopoiesis", J Biol Chem, 289, pp.22600~22613 (2014)
- Park H, "MicroRNA-146a and microRNA-146b regulate human dendritic cell apoptosis and cytokine production by targeting TRAF6 and IRAK1 proteins", J Biol Chem, 290, pp.2831~2841 (2015)
- Zhang HM, "miR-146b-5p within BCR-ABL1-positive microvesicles promotes leukemic transformation of hematopoietic cells", Cancer Res, 76, pp.2901~2911 (2016)
- Ha JS, "Up-regulation of MicroRNA 146b is associated with myelofibrosis in myeloproliferative neoplasms", Ann Clin Lab Sci, 45, pp.308~314 (2015)
- Garzon R, "MicroRNA fingerprints during human megakaryocytopoiesis", Proc Natl Acad Sci U S A, 103, pp.5078~5083 (2006)
- Saito Y, "Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells", Biochem Biophys Res Commun, 379, pp.726~731 (2009)
- Shen WF, "MicroRNA-126 regulates HOXA9 by binding to the homeobox", Mol Cell Biol, 28, pp.4609~4619 (2008)
- Garzon R, "MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia", Blood, 111, pp.3183~3189 (2008)
- O’Connell RM, "Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder", J Exp Med, 205, pp.585~594 (2008)
- Georgantas RW 3rd, "CD34+hematopoietic stem-progenitor cell microRNA expression and function : a circuit diagram of differentiation control", Proc Natl Acad Sci U S A, 104, pp.2750~2755 (2007)